Literature DB >> 116387

Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.

O Ponari, E Civardi, S Megha, M Pini, D Portioli, A G Dettori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 116387     DOI： 10.1016/0049-3848(79)90280-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

Review 1.  The use of sulphonylureas in the elderly.

Authors:  M B Graal; B H Wolffenbuttel
Journal:  Drugs Aging       Date:  1999-12       Impact factor: 3.923

2.  Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide.

Authors:  A E Raptis; N Tountas; A G Yalouris; D Hadjidakis; A Zaharis; K Miras; S A Raptis
Journal:  Acta Diabetol Lat       Date:  1990 Jan-Mar

3.  Effects of diet and gliclazide on the haemostatic system of non-insulin-dependent diabetics.

Authors:  R C Paton; P B Kernoff; J K Wales; G P McNicol
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-17

4.  The effects of gliclazide in diabetes: a comparison with tolbutamide.

Authors:  M J Berber; G H Tomkin
Journal:  Ir J Med Sci       Date:  1982-02       Impact factor: 1.568

Review 5.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 6.  Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

Authors:  B Holmes; R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-04       Impact factor: 9.546

Review 7.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

Review 8.  Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.

Authors:  K J Palmer; R N Brogden
Journal:  Drugs       Date:  1993-07       Impact factor: 9.546

Review 9.  Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).

Authors:  B H Wolffenbuttel; T W van Haeften
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

Review 10.  Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance.

Authors:  R Huupponen
Journal:  Med Toxicol       Date:  1987 May-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.